Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Mammaglobin-A |
Synonyms | |
Therapy Description |
Mammaglobin-A (MAM-A) is a DNA-vaccine, which potentially induces cytotoxic immune response and antitumor activity against tumor cells over expressing MAM-A (PMID: 25451106, PMID: 22678162). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Mammaglobin-A | MAM-A | Mammaglobin-A (MAM-A) is a DNA-vaccine, which potentially induces cytotoxic immune response and antitumor activity against tumor cells over expressing MAM-A (PMID: 25451106, PMID: 22678162). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02204098 | Phase I | Mammaglobin-A | Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy | Active, not recruiting | USA | 0 |